SCYNEXIS Stock

SCYNEXIS Equity Turnover

The Equity Turnover of SCYNEXIS (SCYX) as of Aug 1, 2026 is 0.07. In the previous year, Equity Turnover was 1.92 — a change of -96.46% (lower).

Equity Turnover

0.07

YoY

-96.46%

Last updated:

Equity Turnover of SCYNEXIS is 2026 0.07 . Equity Turnover of SCYNEXIS was 2025 1.92 . It decreases by -96.46% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Equity Turnover of SCYNEXIS is 0.07 in 2026.

Access this data via the Eulerpool API

Profitability — SCYNEXIS

All Key Metrics — SCYNEXIS